Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT04436107 · COMPLETED
Trial details
- NCT number
- NCT04436107
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2024-03-28
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.